Resonance Health Limited (ASX:RHT)
Australia · Delayed Price · Currency is AUD 0.0440
+0.0040 (10.00%)
At close: Jan 22, 2026
Resonance Health Market Cap
Resonance Health has a market cap or net worth of 20.89 million as of January 22, 2026. Its market cap has decreased by -17.99% in one year.
Market Cap
20.89M
Enterprise Value
21.72M
Revenue
11.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since April 25, 1994, Resonance Health's market cap has increased from 1.44M to 20.89M, an increase of 1,347.66%. That is a compound annual growth rate of 8.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 18.99M | -18.37% |
| Dec 31, 2025 | 23.26M | -2.66% |
| Dec 30, 2024 | 23.90M | -14.68% |
| Dec 29, 2023 | 28.01M | 1.25% |
| Dec 30, 2022 | 27.67M | -57.14% |
| Dec 31, 2021 | 64.56M | -39.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 85.10B |
| Pro Medicus | 19.76B |
| Cochlear | 17.57B |
| Sonic Healthcare | 11.40B |
| Ramsay Health Care | 8.43B |
| Ansell | 4.85B |
| Telix Pharmaceuticals | 3.82B |
| Mesoblast | 3.28B |